Viewing Study NCT00320918


Ignite Creation Date: 2025-12-25 @ 4:51 AM
Ignite Modification Date: 2025-12-26 @ 3:52 AM
Study NCT ID: NCT00320918
Status: TERMINATED
Last Update Posted: 2024-01-12
First Post: 2006-04-28
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Chart Review: Unresectable/Metastatic Cholangiocarcinoma Treated With Irinotecan, Capecitabine and Celecoxib
Sponsor: University of New Mexico
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Eligibility Module Contacts Locations Module